In 2025, the reported market value of Japan was USD 16.60 billion.
The Japan Infusion Services Market is forecast to grow to USD 33.82 billion by 2033, with an anticipated CAGR of 9.3% over the forecast horizon.
Population aging continues to anchor systemic therapy demand, with hospital-based oncology infusion remaining dominant under universal reimbursement and tightly controlled drug pricing.
National Cancer Center Japan data indicate sustained treated cancer prevalence, reinforcing stable infusion throughput across designated cancer hospitals nationwide.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]